• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Investor News: Buy shares on the cheap

Article

Bypassing a broker—whether a traditional one or a discounter—can save you some bucks on your next stock purchase.

Bypassing a broker—whether a traditional one or a discounter—can save you some bucks on your next stock purchase. The catch is that you're limited to companies that sell their shares directly to the public, of which there are currently about 430, according to the American Association of Individual Investors (AAII). And your choices aren't restricted to small, untested companies trying to raise capital. The list of firms with direct-purchase plans includes household names such as Fannie Mae, Intel, Lowe's, Pfizer, Procter & Gamble, and Texas Instruments. Minimum initial investment amounts are as low as $25, but are typically $250.

Where do you go to find what stocks that are sold directly to the public? A list can be found at www.wall-street.com/directlist.html.

Related Videos